Global and Japan Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

Global and Japan Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Pharmaceutical
  • 105 pages

Report Description

Global Biologic Therapeutic Drug Scope and Market Size
Biologic Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines

Segment by Application
Clinical Medicine
Laboratory
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
List of Tables
Table 1. Global Biologic Therapeutic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Therapeutic Proteins
Table 4. Key Players of Vaccines
Table 5. Global Biologic Therapeutic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients